Dr. Ted Price Receives Funding From UT’s MD Anderson Cancer Center
Dr. Ted Price received $638,145 from the University of Texas MD Anderson Cancer Center for his research on the Validation of Fibroblast-derived PI16 as a Novel Target for Pain Treatment. The project focuses on testing behavioral validation in mice as…